Missing from the Investor Presentation Odd and worrying that the big changes from the June presenation are what has been removed.
Page 18: "Funding Activity" is GONE..
Troubling as this is Investors biggest question at the moment. Removed all refrence to engaging Greenhill and Co for private placement of Dialco, removed any mention of managing dilution.
Page 15: "DIMI Usability Trial Clinical Partner Activities" GONE.
NO mention of "Confirmed " partners or sites!
How is removing confirmed partners with any info or reasons an Investor Update!
Page 11: Baxter "focused on prelaunch" and info on "stronger than ever" BAxter relationship- GONE.
Pretty worrying. This isn't stacking the deck- this is removing cards from the deck. If we hear of a weak raise in the near future after this "Update".. Tehn they've shown their pention for dirty pool.
There could be other reasons for the removal of this important Investor information... I hope I'm wrong.